Insider · CIK 0001611024

Chang David D

CIK 0001611024 Name as filed on the most recent filing

Filed as Chang David D (20)

41 transaction lines · from 20 filings · filed 2015-06-17 to 2026-03-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

41 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-03-16 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 47,763 disposed 2.47 117,974.61 Form 4, filing 0001737287-26-000013
2026-02-02 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 95,269 disposed 1.80 171,484.20 Form 4, filing 0001737287-26-000009
2025-03-14 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 46,668 disposed 1.96 91,469.28 Form 4, filing 0001737287-25-000042
2025-02-03 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 46,003 disposed 1.68 77,285.04 Form 4, filing 0001737287-25-000017
2022-03-15 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 23,648 disposed 7.65 180,878.82 Form 4, filing 0001214659-22-004085
2021-03-15 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 20,513 disposed 38.57 791,270.51 Form 4, filing 0001214659-21-003240
2020-03-16 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 18,710 disposed 19.24 360,012.21 Form 4, filing 0001214659-20-002734
2020-03-16 Allogene Therapeutics, Inc.
ALLO
S, Open-market sale 1,625 disposed 20.06 32,603.02 Form 4, filing 0001214659-20-002734
2018-10-15 Allogene Therapeutics, Inc.
ALLO
P, Open-market purchase 40,000 acquired 18.00 720,000.00 Form 4, filing 0001209191-18-055374
2017-09-25 Kite Pharma, Inc.
KITE
S, Open-market sale 7,927 disposed 179.66 1,424,195.74 Form 4, filing 0001209191-17-054196
2017-05-01 Kite Pharma, Inc.
KITE
S, Open-market sale 13,795 disposed 81.84 1,128,982.80 Form 4, filing 0001209191-17-029753
2017-05-01 Kite Pharma, Inc.
KITE
S, Open-market sale 5,905 disposed 82.60 487,753.00 Form 4, filing 0001209191-17-029753
2017-05-01 Kite Pharma, Inc.
KITE
S, Open-market sale 300 disposed 83.36 25,008.00 Form 4, filing 0001209191-17-029753
2017-04-03 Kite Pharma, Inc.
KITE
S, Open-market sale 8,697 disposed 82.60 718,372.20 Form 4, filing 0001209191-17-024746
2017-04-03 Kite Pharma, Inc.
KITE
S, Open-market sale 3,939 disposed 79.63 313,662.57 Form 4, filing 0001209191-17-024746
2017-04-03 Kite Pharma, Inc.
KITE
S, Open-market sale 3,549 disposed 82.00 291,018.00 Form 4, filing 0001209191-17-024746
2017-04-03 Kite Pharma, Inc.
KITE
S, Open-market sale 2,424 disposed 80.44 194,986.56 Form 4, filing 0001209191-17-024746
2017-04-03 Kite Pharma, Inc.
KITE
S, Open-market sale 700 disposed 83.66 58,562.00 Form 4, filing 0001209191-17-024746
2017-04-03 Kite Pharma, Inc.
KITE
S, Open-market sale 691 disposed 78.53 54,264.23 Form 4, filing 0001209191-17-024746
2017-03-01 Kite Pharma, Inc.
KITE
S, Open-market sale 55,265 disposed 79.11 4,372,014.15 Form 4, filing 0000899243-17-005893
2017-03-01 Kite Pharma, Inc.
KITE
S, Open-market sale 4,735 disposed 79.71 377,426.85 Form 4, filing 0000899243-17-005893
2016-12-20 Kite Pharma, Inc.
KITE
S, Open-market sale 1,788 disposed 50.86 90,937.68 Form 4, filing 0001209191-16-156547
2015-11-10 Kite Pharma, Inc.
KITE
S, Open-market sale 30,800 disposed 80.02 2,464,616.00 Form 4, filing 0001209191-15-079843
2015-11-02 Kite Pharma, Inc.
KITE
S, Open-market sale 3,923 disposed 71.70 281,279.10 Form 4, filing 0001209191-15-078540
2015-11-02 Kite Pharma, Inc.
KITE
S, Open-market sale 2,800 disposed 70.96 198,688.00 Form 4, filing 0001209191-15-078540
2015-11-02 Kite Pharma, Inc.
KITE
S, Open-market sale 500 disposed 69.52 34,760.00 Form 4, filing 0001209191-15-078540
2015-11-02 Kite Pharma, Inc.
KITE
S, Open-market sale 477 disposed 68.27 32,564.79 Form 4, filing 0001209191-15-078540
2015-10-01 Kite Pharma, Inc.
KITE
S, Open-market sale 7,700 disposed 55.11 424,347.00 Form 4, filing 0001209191-15-073539
2015-09-08 Kite Pharma, Inc.
KITE
S, Open-market sale 7,384 disposed 55.00 406,120.00 Form 4, filing 0001209191-15-069828
2015-09-03 Kite Pharma, Inc.
KITE
S, Open-market sale 316 disposed 55.00 17,380.00 Form 4, filing 0001209191-15-069828
2015-08-03 Kite Pharma, Inc.
KITE
S, Open-market sale 2,900 disposed 71.15 206,335.00 Form 4, filing 0001209191-15-063816
2015-08-03 Kite Pharma, Inc.
KITE
S, Open-market sale 2,276 disposed 72.29 164,532.04 Form 4, filing 0001209191-15-063816
2015-08-03 Kite Pharma, Inc.
KITE
S, Open-market sale 2,205 disposed 72.93 160,810.65 Form 4, filing 0001209191-15-063816
2015-08-03 Kite Pharma, Inc.
KITE
S, Open-market sale 319 disposed 73.87 23,564.53 Form 4, filing 0001209191-15-063816
2015-07-01 Kite Pharma, Inc.
KITE
S, Open-market sale 3,394 disposed 61.15 207,543.10 Form 4, filing 0001209191-15-059224
2015-07-01 Kite Pharma, Inc.
KITE
S, Open-market sale 2,896 disposed 62.31 180,449.76 Form 4, filing 0001209191-15-059224
2015-07-01 Kite Pharma, Inc.
KITE
S, Open-market sale 1,410 disposed 62.97 88,787.70 Form 4, filing 0001209191-15-059224
2015-06-15 Kite Pharma, Inc.
KITE
S, Open-market sale 2,726 disposed 56.93 155,191.18 Form 4, filing 0001209191-15-054394
2015-06-15 Kite Pharma, Inc.
KITE
S, Open-market sale 2,541 disposed 58.04 147,479.64 Form 4, filing 0001209191-15-054394
2015-06-15 Kite Pharma, Inc.
KITE
S, Open-market sale 2,433 disposed 55.93 136,077.69 Form 4, filing 0001209191-15-054394
2014-06-25 Kite Pharma, Inc.
KITE
P, Open-market purchase 4,000 acquired 17.00 68,000.00 Form 4, filing 0001209191-15-054394

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 39
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Chang David D, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001611024

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.